Opticyte
opticyte.com
Opticyte develops the VitalO₂ device, a medical device that provides real-time measurement of cellular and blood oxygen levels to help clinicians detect and treat sepsis, trauma, and respiratory failure. Its technology is designed to deliver accurate results for all skin tones, addressing disparities in current pulse oximetry and aiming to reduce organ failure and death. Opticyte's mission is to bring greater equity to healthcare and improve outcomes for critically ill patients.
Facts
- Sectors
- Medical device, Healthcare, Diagnostics
- Founded
- 2016 Seattle business license
- Type
- Corporation Seattle business license
- Registered name
- Opticyte Inc Seattle business license
- Total raised
- $72.3K SEC Form D filings Total of this company's SEC Form D filings
- Last round
- $72.3K · Sep 2017 SEC Form D
- Founders
- Lori Arakaki, PhD
Is this your organization? Claim it
Executives
-
Lori Arakaki Executive, CEO
